Official recall notice

FDA DrugN/A

Argatroban Injection Recall (Oct 2026) – Par Health and Endo USA

Product: Argatroban Injection 250 mg/2.5 mL (100 mg/mL)

Recall date
2026-10-14
Category
Drug

Why it was recalled

Hazard

Presence of particulate matter, identified as cellulose, polystyrene, polyethylene terephthalate, stopper material, and possibly stainless steel

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Presence of particulate matter, identified as cellulose, polystyrene, polyethylene terephthalate, stopper material, and possibly stainless steel

Verify with the official notice →
Share:

Related Recalls

2026-10-09 · FDA_DRUG
FDA Recall: Par Pharmaceutical: Brevital Sodium 500 mg/vial for Injection
Par Pharmaceutical
2026-10-07 · FDA_DRUG
FDA Recall: Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc.,
Apotex Corp.
2026-10-07 · FDA_DRUG
FDA Recall: FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent M
Aurolab Trust
2026-10-07 · FDA_DRUG
FDA Recall: Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals
Amneal Pharmaceuticals, LLC